SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1

CUSIP: 84763AAB4

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Debt / NOTE 2.750%12/1
Market price (% of par)
88.68%
Total 13F principal
$110,601,000
Principal change
+$45,000
Total reported market value
$98,286,261
Number of holders
18
Value change
-$25,949
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 84763AAB4?
CUSIP 84763AAB4 identifies 84763AAB4 - SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 as of Q1 2016

As of 31 Mar 2016, SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 was held by 18 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $110,601,000 in principal (par value) of the bond. The largest 10 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, FMR LLC, SONORA INVESTMENT MANAGEMENT, LLC, OAKTREE CAPITAL MANAGEMENT LP, TENOR CAPITAL MANAGEMENT Co., L.P., PointState Capital LP, LAZARD ASSET MANAGEMENT LLC, and SSI INVESTMENT MANAGEMENT INC. This page lists 18 institutional bondholders reporting positions for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.